MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
STRATA Skin Sciences Operating Income 2011-2026 | SSKN
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income STRATA Skin Sciences
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.65 M | -4.4 M | -4.08 M | -3.01 M | -3.36 M | -1.8 M | -3.6 M | -16.5 M | -16.6 M | -24.1 M | -22.7 M | -20.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.8 M | -24.1 M | -10.4 M |
Quarterly Operating Income STRATA Skin Sciences
| 2025-Q3 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.17 M | - | -1.6 M | -486 K | -2.89 M | - | -615 K | -1.96 M | -2.59 M | - | -786 K | -1.69 M | -2.3 M | - | -465 K | -923 K | -2.39 M | - | -1.16 M | -1.62 M | -948 K | - | -729 K | -983 K | -1.24 M | - | -370 K | -1.22 M | -1.7 M | - | -512 K | 163 K | -625 K | - | -405 K | -1.46 M | -2.14 M | - | -2.32 M | -9 M | -3.63 M | - | -4 M | -4.26 M | -4.73 M | - | -6.21 M | -7.03 M | -6.49 M | - | -5.37 M | -5.5 M | -5.77 M | - | -6.13 M | -4.83 M | -4.97 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 163 K | -9 M | -2.68 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.22 | -2.57 % | $ 121 M |  France |
 |
Align Technology
ALGN
|
608 M | $ 189.61 | -0.56 % | $ 14.2 B |  USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 12.8 | 0.55 % | $ 1.73 B | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 0.63 | -3.04 % | $ 39.2 M | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 11.78 | 9.58 % | $ 334 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
9.66 M | $ 26.39 | 3.57 % | $ 223 M | USA |
 |
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
480 M | $ 94.87 | 0.52 % | $ 12.8 B | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 2.16 | 4.85 % | $ 1.31 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
-74.4 M | $ 5.33 | 3.5 % | $ 1.13 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 16.19 | -0.12 % | $ 380 M | USA |
 |
LivaNova PLC
LIVN
|
199 M | $ 64.2 | -1.45 % | $ 3.5 B |  Britain |
 |
LENSAR
LNSR
|
-24.6 M | $ 5.09 | -3.23 % | $ 60.9 M | USA |
 |
Pulmonx Corporation
LUNG
|
-53.7 M | $ 1.27 | -0.78 % | $ 51.7 M | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 10.84 | 1.88 % | $ 388 M | USA |
 |
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.06 | 0.95 % | $ 18 M | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 38.34 | 2.24 % | $ 1.19 B | USA |
 |
Inspire Medical Systems
INSP
|
51 M | $ 56.31 | -0.07 % | $ 1.65 B | USA |
 |
Integer Holdings Corporation
ITGR
|
221 M | $ 86.02 | 1.37 % | $ 2.99 B | USA |
 |
PAVmed
PAVM
|
-21.8 M | $ 9.0 | -1.85 % | $ 6.03 M | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 84.15 | 5.56 % | $ 49.2 B | USA |
 |
MiMedx Group
MDXG
|
63.9 M | $ 3.43 | 2.39 % | $ 507 M | USA |
 |
Nevro Corp.
NVRO
|
-126 M | - | - | $ 217 M | USA |
 |
Myomo
MYO
|
-14.4 M | $ 0.82 | 5.52 % | $ 34.3 M | USA |
 |
TELA Bio
TELA
|
-33.8 M | $ 0.7 | 12.54 % | $ 32.9 M | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |